Thyroid cancer
- Study type
- Review article
- Design
- Review article (Review)
- Source
- The Lancet · 2023
In plain words
In recent years, the diagnosis and treatment of thyroid cancer have advanced a great deal. For example, ultrasound scoring systems help reduce unnecessary biopsies, and for low-risk cancers close monitoring or minimally invasive methods can sometimes be used instead of surgery. New systemic (whole-body) drugs are also available for patients with advanced cancer. However, there is still inequality in access to diagnosis and treatment.
Study population
This is a review article and no specific patients were enrolled. The review covers the care of patients with thyroid cancer.
Endpoints
This is a review article and no primary or secondary endpoints were defined.
Safety and side effects
The abstract reports no data on adverse events.
Clinical significance and place in guidelines
This review shows that thyroid cancer care is changing: the use of ultrasound risk stratification systems to reduce unnecessary biopsies, the evaluation of active surveillance and minimally invasive interventions in low-risk cancer, and the availability of new systemic therapies in advanced disease. The abstract stresses the need for population-based studies and randomised trials to develop evidence-based guidelines. The status of clinical guideline recommendations for each point should be checked separately.
Limitations
This is a narrative review and presents no new primary data. The abstract gives no details of the search method or source selection. Further details are available in the full text of the paper.
This summary was prepared by the editorial team from the published paper; the original paper is the final reference. Read the original abstract on PubMed.